GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $141.05 $156.84 Tuesday, 16th Apr 2024 ASND stock ended at $141.50. This is 2.57% less than the trading day before Monday, 15th Apr 2024. During the day the stock fluctuated 5.00% from a day low at $141.05 to a day high of $148.10.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
2024-04-16 $144.53 $148.10 $141.05 $141.50 358 307
2024-04-15 $145.64 $150.11 $145.00 $145.23 375 736
2024-04-12 $151.14 $152.53 $144.36 $146.04 305 361
2024-04-11 $153.85 $154.41 $150.91 $151.04 311 303
2024-04-10 $151.50 $156.84 $151.50 $152.58 419 217
2024-04-09 $149.74 $153.81 $148.30 $153.67 260 843
2024-04-08 $150.97 $150.97 $147.56 $148.88 157 850
2024-04-05 $147.93 $150.62 $145.44 $149.88 156 144
2024-04-04 $150.99 $151.48 $146.60 $147.65 209 745
2024-04-03 $146.45 $150.00 $144.02 $149.50 235 149
2024-04-02 $150.50 $152.81 $146.26 $146.29 329 495
2024-04-01 $151.07 $153.85 $149.34 $151.98 328 540
2024-03-28 $149.15 $151.59 $144.66 $151.17 294 753
2024-03-27 $150.16 $150.65 $146.93 $148.44 240 818
2024-03-26 $145.56 $150.79 $144.96 $149.96 291 980
2024-03-25 $145.73 $147.10 $144.05 $144.46 141 879
2024-03-22 $147.03 $147.99 $144.22 $145.02 173 387
2024-03-21 $145.10 $148.47 $144.75 $146.19 322 371
2024-03-20 $144.84 $146.31 $143.20 $144.23 268 435
2024-03-19 $146.02 $147.00 $144.00 $145.37 606 664
2024-03-18 $149.99 $150.73 $146.77 $147.06 163 814
2024-03-15 $152.06 $152.06 $147.45 $148.70 379 918
2024-03-14 $154.00 $154.85 $149.08 $149.89 231 998
2024-03-13 $153.47 $154.40 $150.20 $153.97 214 929
2024-03-12 $149.20 $155.00 $149.20 $153.80 298 031
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT